1
|
Landwehr VC, Fretwurst T, Heinen J, Vach K, Nelson K, Nahles S, Iglhaut G. Association of sex steroid hormones and new bone formation rate after iliac onlay grafting: a prospective clinical pilot study. Int J Implant Dent 2022; 8:53. [PMCID: PMC9663769 DOI: 10.1186/s40729-022-00447-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/19/2022] [Accepted: 10/05/2022] [Indexed: 11/16/2022] Open
Abstract
Abstract
Purpose
The present prospective study evaluates the association between new bone formation rate in the iliac onlay graft and sex steroid hormone serum levels.
Methods
A total of 15 partially or completely edentulous postmenopausal females and 9 males with less than 5 mm height of the remaining alveolar bone underwent iliac onlay grafting followed by dental implant placement using a two-stage approach. Sex hormone binding globulin and 17β-estradiol serum levels were investigated by electrochemiluminescence immunoassay, while total testosterone level was analyzed using radioimmunoassay. At the time of implant placement, 12 weeks after grafting, bone biopsies were obtained and analyzed histomorphometrically. Statistical analysis was performed using linear mixed models.
Results
Grafting procedure was successfully performed in all patients. The mean new bone formation rate was 32.5% (116 samples). In men the mean new bone formation rate (38.1%) was significantly higher (p < 0.01) than in women (27.6%). Independent of gender 17β-estradiol and testosterone were positively associated to overall new bone formation rate, albeit a significant influence was only seen for 17β-estradiol in men (p = 0.020). Sex hormone binding globulin had no influence on new bone formation rate (p = 0.897). There was no significant association between new bone formation rate and age (p = 0.353) or new bone formation rate and body mass index (p = 0.248).
Conclusion
Positive association of 17ß-estradiol as well as testosterone with new bone formation rate after iliac onlay grafting indicates a role of sex steroid hormones in alveolar bone regeneration, although the observed influence was only significant for 17ß-estradiol in men.
Graphical Abstract
Collapse
|
2
|
Pereira ACM, de Oliveira Carvalho H, Gonçalves DES, Picanço KRT, de Lima Teixeira dos Santos AVT, da Silva HR, Braga FS, Bezerra RM, de Sousa Nunes A, Nazima MTST, Cerqueira JG, Taglialegna T, Teixeira JM, Carvalho JCT. Co-Treatment of Purified Annatto Oil ( Bixa orellana L.) and Its Granules (Chronic ®) Improves the Blood Lipid Profile and Bone Protective Effects of Testosterone in the Orchiectomy-Induced Osteoporosis in Wistar Rats. Molecules 2021; 26:4720. [PMID: 34443306 PMCID: PMC8399955 DOI: 10.3390/molecules26164720] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/08/2021] [Revised: 07/28/2021] [Accepted: 07/30/2021] [Indexed: 01/14/2023] Open
Abstract
This study aimed to evaluate and compare the effects of co-treatment with purified annatto oil (PAO) or its granules (GRA, Chronic®) with that of testosterone on the orchiectomy-induced osteoporosis in Wistar rats. After surgery, rats were treated from day 7 until day 45 with testosterone only (TES, 7 mg/kg, IM) or TES + PAO or GRA (200 mg/kg, p.o.). The following parameters were evaluated: food/water intake, weight, HDL, LDL, glucose, triglycerides (TG), total cholesterol (TC), alkaline phosphatase levels, blood phosphorus and calcium contents, femur weight, structure (through scanning electron microscopy), and calcium content (through atomic absorption spectrophotometry). Our results show that orchiectomy could significantly change the blood lipid profile and decrease bone integrity parameters. Testosterone reposition alone could improve some endpoints, including LDL, TC, bone weight, and bone calcium concentration. However, other parameters were not significantly improved. Co-treatment with PAO or GRA improved the blood lipid profile and bone integrity more significantly and improved some endpoints not affected by testosterone reposition alone (such as TG levels and trabeculae sizes). The results suggest that co-treatment with annatto products improved the blood lipid profile and the anti-osteoporosis effects of testosterone. Overall, GRA had better results than PAO.
Collapse
Affiliation(s)
- Arlindo César Matias Pereira
- Laboratório de Pesquisa em Fármacos, Departamento de Ciências Biológicas e da Saúde, Colegiado de Farmácia, Universidade Federal do Amapá, Macapá 68902-280, AP, Brazil; (A.C.M.P.); (H.d.O.C.); (D.E.S.G.); (K.R.T.P.); (A.V.T.d.L.T.d.S.); (H.R.d.S.); (A.d.S.N.); (M.T.S.T.N.); (J.M.T.)
| | - Helison de Oliveira Carvalho
- Laboratório de Pesquisa em Fármacos, Departamento de Ciências Biológicas e da Saúde, Colegiado de Farmácia, Universidade Federal do Amapá, Macapá 68902-280, AP, Brazil; (A.C.M.P.); (H.d.O.C.); (D.E.S.G.); (K.R.T.P.); (A.V.T.d.L.T.d.S.); (H.R.d.S.); (A.d.S.N.); (M.T.S.T.N.); (J.M.T.)
- Programa de Pós-Graduação em Inovação Farmacêutica, Departamento de Ciências Biológicas e da Saúde, Colegiado de Farmácia, Universidade Federal do Amapá, Macapá 68902-280, AP, Brazil
| | - Danna Emanuelle Santos Gonçalves
- Laboratório de Pesquisa em Fármacos, Departamento de Ciências Biológicas e da Saúde, Colegiado de Farmácia, Universidade Federal do Amapá, Macapá 68902-280, AP, Brazil; (A.C.M.P.); (H.d.O.C.); (D.E.S.G.); (K.R.T.P.); (A.V.T.d.L.T.d.S.); (H.R.d.S.); (A.d.S.N.); (M.T.S.T.N.); (J.M.T.)
| | - Karyny Roberta Tavares Picanço
- Laboratório de Pesquisa em Fármacos, Departamento de Ciências Biológicas e da Saúde, Colegiado de Farmácia, Universidade Federal do Amapá, Macapá 68902-280, AP, Brazil; (A.C.M.P.); (H.d.O.C.); (D.E.S.G.); (K.R.T.P.); (A.V.T.d.L.T.d.S.); (H.R.d.S.); (A.d.S.N.); (M.T.S.T.N.); (J.M.T.)
| | - Abrahão Victor Tavares de Lima Teixeira dos Santos
- Laboratório de Pesquisa em Fármacos, Departamento de Ciências Biológicas e da Saúde, Colegiado de Farmácia, Universidade Federal do Amapá, Macapá 68902-280, AP, Brazil; (A.C.M.P.); (H.d.O.C.); (D.E.S.G.); (K.R.T.P.); (A.V.T.d.L.T.d.S.); (H.R.d.S.); (A.d.S.N.); (M.T.S.T.N.); (J.M.T.)
| | - Heitor Ribeiro da Silva
- Laboratório de Pesquisa em Fármacos, Departamento de Ciências Biológicas e da Saúde, Colegiado de Farmácia, Universidade Federal do Amapá, Macapá 68902-280, AP, Brazil; (A.C.M.P.); (H.d.O.C.); (D.E.S.G.); (K.R.T.P.); (A.V.T.d.L.T.d.S.); (H.R.d.S.); (A.d.S.N.); (M.T.S.T.N.); (J.M.T.)
| | - Francinaldo Sarges Braga
- Laboratório de Absorção Atômica e Bioprospecção, Departamento de Ciências Biológicas e da Saúde, Colegiado de Farmácia, Universidade Federal do Amapá, Macapá 68902-280, AP, Brazil; (F.S.B.); (R.M.B.)
| | - Roberto Messias Bezerra
- Laboratório de Absorção Atômica e Bioprospecção, Departamento de Ciências Biológicas e da Saúde, Colegiado de Farmácia, Universidade Federal do Amapá, Macapá 68902-280, AP, Brazil; (F.S.B.); (R.M.B.)
| | - Alessandro de Sousa Nunes
- Laboratório de Pesquisa em Fármacos, Departamento de Ciências Biológicas e da Saúde, Colegiado de Farmácia, Universidade Federal do Amapá, Macapá 68902-280, AP, Brazil; (A.C.M.P.); (H.d.O.C.); (D.E.S.G.); (K.R.T.P.); (A.V.T.d.L.T.d.S.); (H.R.d.S.); (A.d.S.N.); (M.T.S.T.N.); (J.M.T.)
| | - Maira Tiyomi Sacata Tongo Nazima
- Laboratório de Pesquisa em Fármacos, Departamento de Ciências Biológicas e da Saúde, Colegiado de Farmácia, Universidade Federal do Amapá, Macapá 68902-280, AP, Brazil; (A.C.M.P.); (H.d.O.C.); (D.E.S.G.); (K.R.T.P.); (A.V.T.d.L.T.d.S.); (H.R.d.S.); (A.d.S.N.); (M.T.S.T.N.); (J.M.T.)
| | - Júlia Gomes Cerqueira
- Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte 31270-901, MG, Brazil; (J.G.C.); (T.T.)
| | - Talisson Taglialegna
- Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte 31270-901, MG, Brazil; (J.G.C.); (T.T.)
| | - Janayra Maris Teixeira
- Laboratório de Pesquisa em Fármacos, Departamento de Ciências Biológicas e da Saúde, Colegiado de Farmácia, Universidade Federal do Amapá, Macapá 68902-280, AP, Brazil; (A.C.M.P.); (H.d.O.C.); (D.E.S.G.); (K.R.T.P.); (A.V.T.d.L.T.d.S.); (H.R.d.S.); (A.d.S.N.); (M.T.S.T.N.); (J.M.T.)
| | - José Carlos Tavares Carvalho
- Laboratório de Pesquisa em Fármacos, Departamento de Ciências Biológicas e da Saúde, Colegiado de Farmácia, Universidade Federal do Amapá, Macapá 68902-280, AP, Brazil; (A.C.M.P.); (H.d.O.C.); (D.E.S.G.); (K.R.T.P.); (A.V.T.d.L.T.d.S.); (H.R.d.S.); (A.d.S.N.); (M.T.S.T.N.); (J.M.T.)
- Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte 31270-901, MG, Brazil; (J.G.C.); (T.T.)
| |
Collapse
|